Carter Todd Alfred 4

4 · Voyager Therapeutics, Inc. · Filed Feb 26, 2026

AI-generated summary of this filing

Updated Feb 26, 2026

Voyager (VYGR) CSO Carter Todd Alfred Sells 4,174 Shares

What Happened

Carter Todd Alfred, Chief Scientific Officer of Voyager Therapeutics (VYGR), sold 4,174 shares on 2026-02-24 at a weighted average price of $3.76 per share, generating proceeds of approximately $15,694. The sale was a disposition (S) and was not a discretionary trade.

Key Details

Transaction date: 2026-02-24
Price: weighted average $3.76; individual sale prices ranged from $3.61 to $3.86 (per footnote)
Total proceeds: ~$15,694
Shares owned after transaction: Not specified in the provided filing
Footnotes:
- F1: Sale executed pursuant to a durable automatic sell-to-cover instruction adopted May 12, 2025 to satisfy tax withholding in connection with RSU vesting (vesting occurred Feb 21, 2026). Sales were not discretionary.
- F2: Reported price is a weighted average; full per-price breakdown is available upon request per the Form 4 footnote.
Filing: Form 4 was filed on 2026-02-26 (two days after the transaction); this appears to be within the SEC’s 2-business-day reporting window.

Context

This was a sell-to-cover to satisfy tax withholding after restricted stock units vested, a routine administrative transaction rather than an open-market, discretionary sell. Such transactions are common following RSU vesting and generally reflect tax obligations rather than an expression of the insider’s view on the stock.

Form 4

Period: 2026-02-24

Chief Scientific Officer

Transactions

Footnotes (2)

[F1]Represents shares of common stock of Voyager Therapeutics, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.86, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Signature

/s/ Gregory L. Shiferman, as Attorney-in-Fact for Todd Alfred Carter|2026-02-26

1 file